Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Tongue Neoplasms 1 Mouth Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Communication Disorders 1

Interventions

Cisplatin 30 Magnetic Resonance Spectroscopy 21 Radiotherapy 20 pembrolizumab 18 Specimen Handling 17 Cetuximab 16 Radiotherapy, Intensity-Modulated 11 Paclitaxel 11 Carboplatin 11 Fluorouracil 10 Biopsy 10 1,2-diaminocyclohexaneplatinum II citrate 10 Radiation 9 Platinum 9 Drug Therapy 9 Taxes 7 Surgical Procedures, Operative 7 Celecoxib 7 X-Rays 6 Standard of Care 6 Sentinel Lymph Node Biopsy 6 Surveys and Questionnaires 5 Nivolumab 5 cemiplimab 4 Metformin 4 Fluorodeoxyglucose F18 4 Docetaxel 4 Chemoradiotherapy 4 (225)Ac-DOTA-c(RGDyK) 4 durvalumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mouth Neoplasms × Speech Therapy × Clear all

NCT02584270 2026-05-08

PGSRT

University of Michigan

Phase NA Recruiting

Mouth Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡